8 posts in this category, sorted most recent first.
Supply gaps happen. Pen recalls, pharmacy shortages, prescription delays, travel disruptions. Most patients don't have a plan until the gap is already happening. Here's the framework.
What customs actually cares about, how cold chain works in checked luggage, and the documentation that gets you through any border without a problem.
Eight US telehealth platforms scored against Panya's 11-signal rubric. Three routable (Ro, Calibrate, WW Clinic), one conditional (Found), four hold (Hims, Mochi, Henry, Eden). The April 30 FDA proposal closes the cheap-compounded-supply lane · this is the new map.
A short guide to the seven things on every /vendor/<id> page. The score, the verdict, the per-signal bands, the channel description, the regulatory citations, and the visit-or-hold CTA. What each piece means and what to do with it.
The Panya catalog scores 60+ vendors on the 11-signal rubric. Some land in routable, some in conditional, some in hold. The hold-verdict scorecards are the most useful pages we publish · here is why we keep them and what they do for the people who land on them.
The 11-signal rubric is public. The audits behind every score are run by humans + agents. Both make mistakes. This is the running list of scoring calls we got wrong, what we corrected, and what the editorial process changes in response.
Our public rubric, current as of May 2026. Each of the 11 signals scored 0 to 100, with what a low/mid/high band looks like in practice. The same rubric on every /vendor scorecard, no exceptions.
Most peptide comparison sites are really just attack blogs. We do it differently, on purpose. Here is the logic.